Pfizer Manufacturing Deutschland GmbH
UkraineAll drugs from this manufacturer
-
It is used for the prevention of cardiovascular events in patients with arterial hypertension (high blood pressure) who have three concomitant risk factors and cholesterol levels ranging from normal to moderately elevated. It is also prescribed in cases where diet and other measures do not provide a sufficient effect for lowering lipid levels.
Dosage form: tablets, film-coated
Active substance Dosage amlodipine 5 mg atorvastatin 10 mg ATC: C10BX03
-
The drug is used to treat neuropathic pain (of peripheral or central origin), epilepsy (as adjunctive therapy for partial seizures), generalized anxiety disorder, and fibromyalgia.
Dosage form: capsules
Active substance Dosage pregabalin 150 mg ATC: N03AX16
-
The drug is used for the treatment of neuropathic pain (of peripheral or central origin), epilepsy (as adjunctive therapy for partial seizures), generalized anxiety disorder, and fibromyalgia.
Dosage form: capsules
Active substance Dosage pregabalin 75 mg ATC: N03AX16
-
The drug is used for the treatment of neuropathic pain (peripheral or central origin), epilepsy (as adjunctive therapy for partial seizures), generalized anxiety disorder, and fibromyalgia.
Dosage form: capsules
Active substance Dosage pregabalin 50 mg ATC: N03AX16
-
The drug is used to treat neuropathic pain (of peripheral or central origin), epilepsy (as adjunctive therapy for partial seizures), generalized anxiety disorder, and fibromyalgia.
Dosage form: capsules
Active substance Dosage pregabalin 300 mg ATC: N03AX16
-
The drug is prescribed for adults for the treatment of advanced non-small cell lung cancer (both ALK-positive and ROS1-positive), as well as for children (from 2 to 18 years old) for the treatment of certain types of lymphoma (ALK+ diffuse large B-cell lymphoma) and tumors (anaplastic large cell lymphoma) that are ALK-positive.
Dosage form: capsules
Active substance Dosage crizotinib 200 mg ATC: L01ED01
-
The drug is used for the treatment of adults with advanced non-small cell lung cancer (NSCLC) that is ALK-positive or ROS1-positive. It is also indicated for the treatment of children (aged 6 to 18 years) with certain types of lymphoma (ALCL) or tumors (SMT) that are ALK-positive.
Dosage form: capsules
Active substance Dosage crizotinib 250 mg ATC: L01ED01